Study guide

Medication Management in HD

CDN Certified Dialysis Nurse Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Exam Map and Kidney Disease

CDN Exam Format and Blueprint CKD, AKI, and Stages of Kidney Disease Uremia, Fluid, and Electrolyte Imbalance Anemia, Bone Mineral, and Comorbidities Patient Assessment and Lab Interpretation

2 Hemodialysis Core

HD Principles and Dialysis Adequacy (Kt/V, URR) Vascular Access: AVF, AVG, and Catheters Dialyzers, Dialysate, and Water Treatment HD Machine Setup and Monitoring Anticoagulation and Circuit Management

3 Hemodialysis Complications

Intradialytic Hypotension and Cramps Access Complications and Infection Dialyzer Reactions and Air Embolism Medication Management in HD Patient Education and Self-Care in HD

4 Peritoneal Dialysis

PD Modalities: CAPD and APD PD Catheters and Exchange Technique Peritonitis and Exit-Site Infection PD Adequacy and Ultrafiltration PD Troubleshooting and Patient Training

5 Transplant, Acute Therapies, and Exam Day

Kidney Transplant Basics for CDN CRRT and Acute Kidney Therapies Infection Control and Safety Across Modalities CDN Exam Strategy and Review

Medication Management in HD

Key Takeaways Explain This Topic AI

IV epoetin, iron, and vitamin D analogs are typically administered in the last 30 minutes of dialysis to limit dialytic clearance.

Gabapentin is renally cleared and requires marked dose reduction in ESRD to prevent neurotoxicity.

Aminoglycosides, vancomycin, and digoxin are dialyzable and need timing or levels coordinated with the dialysis schedule.

Heparin is standard circuit anticoagulation but is contraindicated with active bleeding or heparin-induced thrombocytopenia.

Heparin-free dialysis relies on periodic saline flushes and adequate blood flow to prevent circuit clotting.

Last updated: July 2026

Medication Management in HD

Quick Answer: Hemodialysis removes many drugs depending on molecular weight, protein binding, volume of distribution, and membrane flux. IV iron, epoetin, and vitamin D analogs are often given in the last 30 minutes of treatment. Gabapentin, aminoglycosides, digoxin, and vancomycin require individualized dosing around dialysis sessions.

Medication management is a cross-cutting CDN domain linking pharmacokinetics to the dialysis prescription. Questions test what to hold , when to dose , what to give on dialysis , and what accumulates in renal failure.

How Hemodialysis Affects Drug Levels

Drug removal during HD depends on:

  • Molecular size and protein binding (highly bound drugs like warfarin are poorly removed)
  • Volume of distribution (large Vd drugs such as digoxin are partially removed but redistribution matters)
  • Membrane flux (high-flux removes middle molecules more efficiently)
  • Blood flow rate and treatment time
  • Residual renal function (still significant in some incident patients)

Nurses do not independently redesign regimens, but must recognize when orders need nephrology input and administer medications at the correct dialysis timing to avoid loss or toxicity.

  • Property Dialyzability CDN example
  • Small, water-soluble, low protein binding High Aminoglycosides, vancomycin
  • Large Vd, high protein binding Low Warfarin, most statins
  • Renally cleared, not dialyzed well Accumulates Gabapentin
  • Medications Commonly Given During Dialysis

Many parenteral renal medications are administered IV during the last 30 minutes of hemodialysis to minimize clearance into dialysate:

  • Medication class Examples Nursing note
  • ESA Epoetin alfa, darbepoetin Monitor Hgb; hypertension risk
  • IV iron Iron sucrose, ferric gluconate Test dose per policy; watch anaphylaxis
  • Active vitamin D Paricalcitol, calcitriol Monitor calcium and PTH
  • Antibiotics Vancomycin (dosing per level), ceftazidime Often post-HD or supplemental dose

Giving these agents early in treatment can reduce efficacy because substantial drug is cleared before session end.

Drugs Requiring Dose Reduction or Timing Adjustment

Renally cleared drugs with high dialysis removal need post-dialysis supplemental doses or extended intervals:

  • Aminoglycosides (gentamicin, tobramycin)—dose after HD; monitor levels
  • Vancomycin —depends on flux and schedule; trough-guided
  • Digoxin —partially removed; toxicity risk if doses not adjusted

Gabapentin —accumulates in ESRD; typical HD dose 100–300 mg after each session versus daily dosing in normal renal function

Gabapentin is a classic CDN trap: it is renally excreted and causes neurotoxicity (sedation, dizziness) when standard doses are used in anuric patients.

  • Medications Often Held or Used Cautiously
  • Metformin —contraindicated in advanced CKD/ESRD (lactic acidosis risk)
  • ACE inhibitors/ARBs —sometimes held on dialysis day to reduce IDH

Heparin —contraindicated or minimized with active bleeding, severe thrombocytopenia, or HIT; saline flush protocols replace anticoagulation

  • NSAIDs —avoid in CKD (hemodynamic renal effects, GI bleeding with heparin)
  • Anticoagulation During HD

Unfractionated heparin is the standard circuit anticoagulant, often started with a bolus then infusion titrated to keep the venous line clear. Activated clotting time (ACT) may guide dosing—typical target ranges vary by unit (often roughly 200–250 seconds during treatment).

Heparin-free dialysis uses periodic saline flushes (commonly every 15–30 minutes ) and requires adequate blood flow rate (often ≥250–300 mL/min) to limit clotting. Patients with bleeding risk, recent surgery, or HIT require alternative plans.

Worked Scenario: Post-Dialysis Antibiotic

A patient receives gentamicin for access infection. She dialyzes Monday-Wednesday-Friday mornings.

Analysis: Aminoglycosides are dialyzable; dosing after hemodialysis with level monitoring prevents subtherapeutic concentrations. Administering the full daily dose before dialysis would remove most of the drug.

Nursing role: verify order matches dialysis schedule, document administration time relative to treatment end, monitor for ototoxicity and nephrotoxicity (residual function).

Phosphate Binders and Oral Agents

Oral phosphate binders (sevelamer, calcium acetate, lanthanum) are taken with meals , not during dialysis clearance windows. Cinacalcet lowers PTH and serum calcium—watch for hypocalcemia symptoms.

Teach patients that non-adherence to binders drives hyperphosphatemia and vascular calcification—medication management includes education, not only IV drugs.

Medication Reconciliation at Each Treatment

Compare home medication list to dialysis-day orders. Common errors: duplicate antihypertensive after hold order, missed post-HD antibiotic, IV iron given at session start. Document holds and administrations in the medical record per facility policy.

CDN Exam Traps

Trap: Give IV epoetin at dialysis start. Correct: Typically last 30 minutes to reduce dialytic loss.

Trap: Gabapentin needs no adjustment in ESRD. Correct: Requires major dose reduction and often post-HD timing.

Trap: All anticoagulation is always safe on dialysis. Correct: Active bleeding or HIT contraindicate standard heparin.

Trap: Vancomycin once daily before HD is always therapeutic. Correct: Levels and supplemental dosing depend on schedule and flux.

ESA and Iron Monitoring

ESA therapy requires monitoring hemoglobin and blood pressure—rapid Hgb rise increases stroke risk. IV iron requires test-dose policies where ordered and observation for anaphylaxis. Document pre-dialysis Hgb and iron studies per monthly protocol.

Oral Agents on Dialysis Days

Phosphate binders and sevelamer are home medications—verify patients brought them or document teaching if doses were missed. Vitamin D analogs given IV during HD differ from over-the-counter supplements—clarify with patients to prevent duplication.

Medication reconciliation at every treatment prevents the duplicate or missed doses that cause HD patients disproportionate harm.